Enhancement of (211)At Uptake via the Sodium Iodide Symporter by the Addition of Ascorbic Acid in Targeted α-Therapy of Thyroid Cancer

(211)At is an α-emitter that has similar chemical properties to iodine and is used in targeted α-therapy. In the present study, we added ascorbic acid (AA) to (211)At solution to increase the radiochemical purity of astatide and evaluated its efficacy against differentiated thyroid cancer, which is...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:J Nucl Med
Egile Nagusiak: Watabe, Tadashi, Kaneda-Nakashima, Kazuko, Liu, Yuwei, Shirakami, Yoshifumi, Ooe, Kazuhiro, Toyoshima, Atsushi, Shimosegawa, Eku, Fukuda, Mitsuhiro, Shinohara, Atsushi, Hatazawa, Jun
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Society of Nuclear Medicine 2019
Gaiak:
Theranostics
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6735285/
https://ncbi.nlm.nih.gov/pubmed/30796173
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2967/jnumed.118.222638
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak